PROMOTING HUMAN PAPILLOMA VIRUS VACCINE TO PREVENT GENITAL WARTS AND CANCERS
and young men aged 11–26, expanding the role of primary prevention in HPV related cancers.
Whilethe recommendations are for vaccinations startingat age 11, they “can be started as young as age 9years.” On February 27, 2012, the American Academyof Pediatrics updated its vaccination guidelinesto reflect these recommendations.
Studies haveshown that vaccination remains cost effective forMSM up to age 26.
Many doctors offer HPVimmunizations to men older than 26, especially if they believe that they have notbeen exposed to the virus.As of 2010 the Centers forDisease Control and Prevention
Morbidity and Mortality WeeklyReport
reported that only 32%of eligible adolescent girls aged13–17 in the U.S. completed thethree-dose regimen of eitherquadrivalent or bivalent HPV vaccine. Idahoand Arkansas had the lowest rates of coveragefor adolescent girls, below 20%. Six states hadvaccination rates of above 40% for girls: Colorado,Connecticut, Delaware, Massachusetts, Nebraska,and New Hampshire. New York City’s vaccinationrate was also above 40%, but in the rest of NewYork State only 37.9% had had all three dosesof the HPV vaccine. As of 2010 only 1.4% of adolescent boys had initiated the vaccinationprotocol, although at the time the data werecollected from the National Immunization Survey—Teen, HPV vaccine for adolescent boys was notyet part of ACIP’s recommendations.
We hopethat vaccination rates among boys and young menwill increase as word of the ACIP recommendationgets out and pediatricians and other providerspromote HPV vaccine for boys and young men.
ACIP recommendation is a significant step towardwidespread implementation of HPV vaccinationto eligible recipients. Under the Affordable CareAct, all new private insurance plans are requiredto cover ACIP-recommended vaccinations withoutcost-sharing in the next plan year that occurs oneyear after the date of the recommendation.
Thiswould mean that many insurers must fully coverHPV vaccine for boys and young men starting inDecember 2012, one year after the Centers forDisease Control and Prevention journal
Morbidityand Mortality Weekly Report
published the ACIPrecommendation.
(Benefit year start dates varyfrom employer to employer.) However, someinsurance plans will be grandfathered under ACAand not required to cover ACIP-recommendedvaccinations.
And the Vaccines for Children(VFC) program provides vaccines at no cost toMedicaid eligible recipients.In Massachusetts, all of the major private insuranceproviders and MassHealth, the Commonwealth’sMedicaid program, cover HPV for boys and youngmen.
In August, 2011, Blue Cross/Blue Shield of Massachusetts, the largest insurance provider inthe Commonwealth, announced it would coverHPV vaccination for all recommended patients inanticipation of the new guidelines expected later
Only 32% of adolescent girlsaged 13–17 in the U.S. havecompleted the three-doseHPV vaccine.